FOOTNOTES±Transitions, the Transitions logo, and Transitions Light Intelligent Technology are trademarks of Transitions Optical, Inc. used under license by Transitions Optical Limited and Johnson & Johnson Vision Care, Inc.
¥22 clinical studies posted on ClinicalTrials.gov, a website maintained by the NIH, evaluated subjective comfort as primary or secondary endpoint for ACUVUE® OASYS Brand 2-week family contact lenses vs. competitors’ products as of April 30, 2023.
‡www.clinicaltrials.gov is a website maintained by the NIH. Since February 2007, 28 clinical studies evaluated subjective comfort as a primary or secondary endpoint for ACUVUE® OASYS Brand families of contact lenses vs. competitors’ products. Review conducted as of April 30, 2023.
*Source Euromonitor International Limited; Eyewear 2024 edition; value sales at rsp, all retail channels, 2022 data; “Acuvue family of brands” represents aggregated sales of the following brands: 1-day Acuvue, Acuvue Oasys, Acuvue Advance, Acuvue, and Acuvue2.
+Source Euromonitor International Limited; Eyewear 2023 edition; value sales at rsp, all retail channels, 2021 data; “Acuvue family of brands” represents aggregated sales of the following brands: 1-day Acuvue, Acuvue Oasys, Acuvue Advance, Acuvue, and Acuvue2.
#Helps protect against transmission of harmful UV radiation to the cornea and into the eye
^WARNING: UV-absorbing contact lenses are NOT substitutes for protective UV-absorbing eyewear such as UV-absorbing goggles or sunglasses because they do not completely cover the eye and surrounding area. You should continue to use UV-absorbing eyewear as directed. NOTE: Long-term exposure to UV radiation is one of the risk factors associated with cataracts. Exposure is based on a number of factors such as environmental conditions (altitude, geography, cloud cover) and personal factors (extent and nature of outdoor activities). UV-blocking contact lenses help provide protection against harmful UV radiation. However, clinical studies have not been done to demonstrate that wearing UV- blocking contact lenses reduces the risk of developing cataracts or other eye disorders. Consult your eye care practitioner for more information. †Includes Air Optix Aqua, Avaira, Biofinity, and Ultra. **Individual baseline responses were collected from 1 to 44 clinical trials of current spherical, daily wear reusable SiHy wearers in the United States ages 18-45 over a 3-year period. The number of analyzed subjects for each response ranged from 212 to 3,495.
‡Includes Air Optix Aqua, Avaira, Biofinity, and Ultra
REFERENCES
1. JJV Data on File 2018. Material Properties: ACUVUE OASYS Brand Contact Lenses with HYDRACLEAR PLUS, ACUVUE OASYS with Transitions Light Intelligent Technology, and other reusable contact lenses.
2. JJV Data on File 2017. Subjective Responses of ACUVUE(R) OASYS Brand Contact Lenses and Habitual Contact Lenses during Digital Device Usage
3.JJV Data on File 2018. Similarities between Mucin and Poly(N-Vinyl Pyrrolidone) (PVP).
4. JJV Data on File 2017. A 4-week randomized, masked, controlled, cross-over, dispensing daily wear study with ACUVUE OASYS vs. ULTRA, n=127 subjects who spent greater than or equal to 8 hours per day using digital devices during the study period.
5.JJV Data on File 2018. ACUVUE Brand UV Claims.
6.Fadli Z, Mahadevan S, Scales C. Antioxidant Capacity of a Phenolic Benzotriazole (Norbloc) in Soft Contact Lens Materials: A Benefit Beyond UV Blocking. Invest. Ophthalmol. Vis. Sci. 2018;59:1759.
7.JJV Data on File 2022: Master Brand Claims on Clinical Performance and Overall Material Properties for ACUVUE Brand Soft Contact Lenses.
PP2023MLT6356
